Skip to main content
logo
Oncopeptides AB (publ) (STO:ONCO)
Sweden flag Sweden · Delayed Price · Currency is SEK
2.500
+0.196 (8.51%)
Sep 25, 2026, 5:29 PM CET

Oncopeptides AB Ratios and Metrics

Millions SEK. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
9881,3103357251,146632
Market Cap Growth
-21.82%291.35%-53.79%-36.76%81.18%-94.51%
Enterprise Value
9661,311202599724-39
Last Close Price
2.504.531.384.867.705.32

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
10.3918.4310.5820.58137.155.35
PB Ratio
39.64-22.256.1712.763.893.00
P/TBV Ratio
39.64-6.1712.763.893.02

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
10.1518.446.3817.0186.70-

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
5.42-2.372.612.310.020.07
Net Debt / Equity Ratio
-0.90-0.97-0.68-0.74-1.15-1.66
Net Debt / EBITDA Ratio
0.12-0.260.130.170.980.24
Net Debt / FCF Ratio
0.12-0.260.140.150.800.23
Asset Turnover
0.530.380.130.110.020.17
Inventory Turnover
0.360.390.78---
Quick Ratio
3.572.193.744.264.221.78
Current Ratio
3.782.614.234.524.251.83
Return on Equity (ROE)
---512.51%-141.91%-133.80%-363.13%
Return on Assets (ROA)
-68.27%-74.30%-73.20%-50.66%-52.59%-134.59%
Return on Capital Employed (ROCE)
-117.40%-249.80%-146.50%-130.70%-115.80%-697.10%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-21.55%-19.05%-85.00%-34.38%-29.49%-226.15%
FCF Yield
-19.08%-17.01%-77.93%-38.59%-36.92%-239.82%
Buyback Yield / Dilution
-32.63%-36.37%-84.14%-9.80%-9.33%-20.72%